Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn updated revision tag now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects an administrative update to the page's version identifier rather than a substantive change to content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3 label. This reflects a small update to the page's revision history or template without changing the study information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. This update does not change any study details or user-facing content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows revision v3.6.2 as the current version, replacing the prior v3.6.0.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Publications section loses a citation for Reck et al., Pembrolizumab vs Chemotherapy in PD-L1-positive NSCLC (KEYNOTE-024, NEJM 2016).SummaryDifference0.1%

- Check72 days agoChange DetectedRecruitment status is updated to indicate no longer seeking participants. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and implements minor formatting changes to the Intervention/Treatment header, along with a new revision tag (v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.